GNH USA

Europe — EMA

Teceos

Teceos (3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt) is a radiopharmaceutical agent used in nuclear medicine imaging. This sterile injectable

3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt (Dpd)

Request sourcing

1
Pack/s

What is 3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt (Dpd)?

Teceos (3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt) is a radiopharmaceutical agent used in nuclear medicine imaging. This sterile injectable solution aids in diagnostic procedures by enhancing imaging clarity. Teceos is administered intravenously under professional supervision for accurate results.

What is 3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt (Dpd) used for?

Teceos is primarily used as a diagnostic aid in nuclear medicine imaging procedures. It helps improve the visibility of certain tissues or abnormalities during scans, particularly in bone scintigraphy. Healthcare providers may use Teceos to assess skeletal conditions, monitor treatment progress, or detect areas of abnormal metabolic activity. This agent is not a standalone treatment but supports accurate diagnostic evaluations.

What are the side effects of 3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt (Dpd)?

After intravenous administration, Teceos distributes throughout the body and accumulates in areas of high bone turnover or abnormal metabolic activity. The agent enhances the contrast of imaging scans, making it easier to identify and evaluate potential issues. Patients may experience mild discomfort at the injection site, but systemic effects are generally minimal. The imaging process itself does not produce pain or discomfort beyond the initial injection.

What precautions apply to 3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt (Dpd)?

Teceos should only be handled and administered by trained healthcare professionals in a controlled clinical setting. Patients with known allergies to tetrasodium salts or related compounds should inform their provider before use. Pregnant or breastfeeding individuals should discuss potential risks with their healthcare team. Proper disposal of unused or expired Teceos is essential to prevent environmental contamination.

What does 3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt (Dpd) interact with?

No significant drug interactions have been widely reported with Teceos, but patients should disclose all medications, supplements, or recent medical procedures to their healthcare provider. Certain imaging agents or contrast media may interfere with scan results, so coordination between providers is important. Alcohol and other substances do not typically interact with Teceos but should be avoided if recommended by a physician.

Frequently asked questions

What is Teceos used for?+
Teceos is used as a diagnostic aid in nuclear medicine imaging, particularly for bone scans.
How is Teceos administered?+
Teceos is given as an intravenous injection by a healthcare professional during imaging procedures.
Are there side effects of Teceos?+
Mild discomfort at the injection site is possible, but systemic side effects are generally minimal.
Can Teceos be used during pregnancy?+
Pregnant individuals should consult their healthcare provider before using Teceos.
Is Teceos available over the counter?+
No, Teceos is a prescription-only radiopharmaceutical agent.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt (Dpd)
Route
Intravenous Use
Manufacturer
Cis Bio International
Origin
EU

Related products